Physical Activity Level in Patients with Chronic Kidney Disease During COVID-19 Pandemic

Hacettepe University190 enrolled

Overview

In the literature, there are no studies evaluating fear of COVID-19, anxiety, depression, physical activity, fear of movement and quality of life in patients with chronic kidney disease during COVID-19 pandemic. The investigators will evaluate these parameters in patients with chronic kidney disease and compare the findings of healthy individuals during COVID-19 pandemic

Study Type

OBSERVATIONAL

Enrollment

190

Conditions

Covid19 Chronic Kidney Diseases

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Having been diagnosed with chronic kidney disease * Being clinically stable * Volunteering to participate in the research Exclusion Criteria: * Having a cognitive problem * Not being literate

Locations (1)

Hacettepe University, Faculty of Physical Therapy and Rehabilitation

Ankara, Turkey (Türkiye)

Outcomes

Primary Outcomes

Fear of COVID-19

COVID-19 phobia will be evaluated using Fear of COVID-19 Scale.

Time frame: 5 minutes

Physical activity

Physical activity level will be evaluated using International Physical Activity Questionnaire - Short Form (IPAQ-SF).

Time frame: 5 minutes

Secondary Outcomes

Qol

Quality of life will be evaluated using SF-36

Time frame: 10 minutes

Anxiety and depression

Anxiety and depression will be evaluated using Hospital Anxiety and Depression scale (HADS).

Time frame: 5 minutes

Fear of movement

Fear of movement will be evaluated using the Tampa Scale for Kinesiophobia

Time frame: 10 minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.